FDA Adverse Event Malfunction Summary report: N

PARADIGM REAL-TIME REVEL INSULIN INFUSION PUMP

MDR report key: 6205246 · Received December 27, 2016

Doing adverse event research by hand?

The Research Assistant searches MAUDE for you, groups reports by failure mode, and cites every record.

Free to try · every answer cites its records

Report

Report Number
2032227-2016-52777
Event Type
Malfunction
Date Received
December 27, 2016
Date of Event
March 2, 2014
Report Date
March 2, 2014
Manufacturer
MEDTRONIC MINIMED
Product Code
OYC
PMA / PMN Number
P980022
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NC
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. NOTE: THIS IS A REMEDIATION MDR. MEDTRONIC DIABETES IMPLEMENTED REVISED MDR REPORTABILITY CRITERIA EFFECTIVE ON (B)(6) 2014. SUBSEQUENTLY, MEDTRONIC DIABETES CONDUCTED A ONE YEAR RETROSPECTIVE REVIEW OF COMPLAINTS. THIS EVENT WAS RETROSPECTIVELY IDENTIFIED TO BE REPORTABLE BASED ON THE REVISED MDR REPORTABILITY CRITERIA.

Description of Event or Problem · 1

THE CUSTOMER REPORTED VIA PHONE CALL THAT THE RESERVOIR HAD AN OCCLUSION. THE BLOOD GLUCOSE AT THE TIME OF THE INCIDENT WAS 240 MG/DL. THE CUSTOMER PERFORMED TROUBLESHOOTING FOR THE NO DELIVERY ALARM. HOWEVER THE INSULIN DID NOT EXIT, BUT IT DID NOT ALARM NO DELIVERY. THE CUSTOMER WAS INFORMED THERE MAY NOT HAVE BEEN ENOUGH BACK PRESSURE AND WOULD NEED TO PERFORM A COMPLETE SET CHANGE. THE CUSTOMER STATES THEY DID A COMPLETE SET CHANGE, BUT WAS NO CLEAR IF IT RESOLVED THE ISSUE. THE DEVICE WILL NOT BE RETURNED FOR ANALYSIS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
857173 PARADIGM REAL-TIME REVEL INSULIN INFUSION PUMP INSULIN INFUSION PUMP / SENSOR AUGMENTED OYC MEDTRONIC MINIMED MMT-723RNAH

Patients

Seq Age Sex Outcome Treatment
1 66 YR